HOSPITALIZATION BURDEN AMONG DIALYSIS PATIENTS IN BRAZIL- AN ANALYSIS OF THE PUBLIC HEALTH SYSTEM DATABASE

Author(s)

Coutinho MB1, Custodio MR2, Pecoits-Filho R3, Borges L4, Guersoni AC1
1Amgen Brazil, Sao Paulo, Brazil, 2Federal University of Uberlandia, Sao Paulo, Brazil, 3Pontifícia Universidade Católica do Paraná, Curitiba, Brazil, 4Evidências, Campinas, Brazil

OBJECTIVES The objective is to compare the hospitalization length of stay and costs associated with comorbidities between dialysis patients and non-dialysis patients. METHODS This was a cross-sectional observational study (from January to December 2010) of a national hospitalization database from the Brazilian Unified Public Healthcare System (Sistema Único de Saúde – SUS). Patients included in the study were hospitalized due to 3 predefined comorbidities categories: heart disease, vascular disease, and osteometabolic diseases, identified using ICD-10 codes.   RESULTS A total of 491,644 admissions were observed in patients not on dialysis (control group), while 2,627 admissions were identified in dialysis patients. The comparative analysis of causes of hospitalization showed that a larger proportion of admissions due to heart disease was observed in patients on dialysis (61%) compared to the control group (47.9%), the opposite was observed for vascular and osteometabolic hospitalizations.  For all 3 categories, cost of hospitalization for dialysis patients is at least two-fold higher and the length of stay almost 3 times longer (21 days for dialysis patients versus 8 days for non-dialysis) than non-dialysis patients. The greatest differences between these two patient populations are in average costs among dialysis patients hospitalized for osteometabolic disorders versus control group and the highest burden regarding length of hospital stay, due to heart disease. CONCLUSIONS There is a high hospitalization burden among CKD-5D patients in the Brazil health care system. Since inpatient costs were the key cost drivers for CKD, strategies that reduce the risk of hospitalization and increase prevention of comorbidities may substantially decrease the overall healthcare economic burden.

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PMS27

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Cardiovascular Disorders, Musculoskeletal Disorders, Urinary/Kidney Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×